In vitro screening is a critical component in identifying candidate compounds for clinical development. In Vitro assays serve as surrogates and indicators to better predict absorption, distribution, metabolism and excretion of a compound in vivo and assess potential drug-drug interactions.
BRC provides cost-effective solutions for both standard and custom in vitro protocols with high quality and reproducible results in a short lead time.
